Search
Filter by content type
Filter by content year
BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024
March 6, 2024 - … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, …
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
April 22, 2024 - … collaborators, including Biotheus, DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, … collaborators, including Biotheus, DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, … collaborators, including Biotheus, DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, …
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
May 17, 2024 - … collaborators, including Biotheus, DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, … collaborators, including Biotheus, DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, … collaborators, including Biotheus, DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, …
BioNTech Receives Science Based Targets Initiative Validation for Near-term Emissions Reduction Targets
February 12, 2024 - … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, …
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
March 20, 2024 - … collaborators, including Biotheus, DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, … collaborators, including Biotheus, DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, … collaborators, including Biotheus, DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, …
BioNTech Announces Planned Retirement of Sean Marett
March 7, 2024 - … global pharmaceutical collaborators, including DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, … global pharmaceutical collaborators, including DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, … global pharmaceutical collaborators, including DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, …
BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
March 11, 2024 - … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, …
BioNTech veröffentlicht am 20. März 2024 Ergebnisse für das vierte Quartal und das Geschäftsjahr 2023 und informiert über operativen Fortschritt
March 6, 2024 - … aus der pharmazeutischen Industrie, darunter DualityBio, Fosun Pharma, Genentech (ein Unternehmen der Roche Gruppe), … aus der pharmazeutischen Industrie, darunter DualityBio, Fosun Pharma, Genentech (ein Unternehmen der Roche Gruppe), … aus der pharmazeutischen Industrie, darunter DualityBio, Fosun Pharma, Genentech (ein Unternehmen der Roche Gruppe), …
BioNTech veröffentlicht am 6. Mai 2024 Ergebnisse für das erste Quartal 2024 und informiert über operativen Fortschritt
April 22, 2024 - … pharmazeutischen Industrie, darunter Biotheus, DualityBio, Fosun Pharma, Genentech (ein Unternehmen der Roche Gruppe), … pharmazeutischen Industrie, darunter Biotheus, DualityBio, Fosun Pharma, Genentech (ein Unternehmen der Roche Gruppe), … pharmazeutischen Industrie, darunter Biotheus, DualityBio, Fosun Pharma, Genentech (ein Unternehmen der Roche Gruppe), …
BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305
January 31, 2024 - … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, …